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cos. ConClusiones: Es factible implementar los IMA en 48-72 hs, para responder 
a consultas puntuales acotadas. El perfil fue diferente al de los informes de ETS 
tradicionales. Los IMA más solicitados fueron aquellos relacionados con tecnologías 
terapéuticas, siendo el área oncológica la más frecuente.
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objeCtives: Health technology assessment in Latin America has been relatively 
more mature than other similarly developed health systems. This research explores 
the trends of development of HTA in the region to understand similarities to the 
European HTA model. It further looks at relevance of having such a model in Latin 
America, the relevance of the complexity of the methodologies and utilities used 
and finally, the implications of these trends. Methods: The study was conducted 
in Brazil, Mexico, Argentina and Columbia. Opinions of 18 stakeholders were col-
lected via telephone interviews. Respondents included senior clinical oncologists(3), 
academics(4), policy advisors(2), senior bureaucrats in the health ministries(3), senior 
members of HTA bodies(4) and senior executives from manufacturers(2). A scoring 
system was devised to plot the level of complexity and maturity of the HTA systems 
/ agencies both in Latin America and then comparing it with scores of a similar 
study across Europe and Australia. The responses around the relevance of the model 
and implications were analysed qualitatively adding perspective from the author’s 
experience in these countries. Results: The level of maturity of HTA processes in 
all the countries studied was seen to be generally high. The level of association with 
reimbursement processes was seen to vary. There was a split on the relevance of the 
European model to the Latin American context. Majority of the academics (n= 3/4) and 
members of HTA bodies (n= 2/4) felt that following highly complex European models 
was a necessary natural progression to the HTA development curve. This was not 
the observation with the rest of the stakeholders. ConClusions: There is thought 
to be a trend where there is a push by academics and HTA-related professionals 
towards making it similar to the European model, and thus increasingly complex. 
Greater international attention can be a reason, although it must be further explored.
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objeCtives: Establishing an active postmarketing safety surveillance and analysis 
system, used by health professionals, regulatory bodies and sponsors. Methods: 
The solution consists in making available to the entire community a set of online 
tools aimed to the data collection and analysis on innovative drugs. The introduc-
tion of online integrated environments ensures the appropriate use of drugs, help to 
monitor drug consumption and related costs and improves the real-time reporting 
of suspected adverse drug events. The surveillance system collects patients data in a 
common IT infrastructure within the same network. For 24 antineoplastic drugs the 
system provides also automatic procedures to manage the ‘risk sharing’ & ‘payment 
by result’ approach, that foresees partial or total refund of the cost sustained by 
the hospital pharmacy for the drug in case of progressive disease or unacceptable 
toxicity. Results: This presentation will illustrate the Cineca methodological IT 
approach used also by the Italian National Medicines Agency. The system has been 
used for 70 innovative drugs from eleven different drugs categories: antineoplastic, 
antidiabetics, neurological, dermatological, antiasmatics, ophtalmologic, antireu-
matics and others. More than 500.000 patients were registered by more than 900 
health structures in a timeframe of 7 years. ConClusions: The introduction of 
an online integrated environments ensures a more appropriate drug usage, help to 
monitor drug consumption and related costs and improves the real-time reporting 
of suspected adverse drug events.
HeAltH cAre use & Policy studies – Population Health
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objeCtives: Chile carried out a health care system reform in 2005 aimed at reduc-
ing health and health care inequities. This study assessed whether household 
income-related inequality in adult self-reported health status (SRHS) was reduced 
after this reform. Methods: Before and after study design using the 2000 and 2009 
CASEN surveys (252 748 and 246 924 participants, respectively) we compared the 
Erreygers concentration index (CI) for SRHS (binary variable: poor= 0, fair/good= 1) 
between these two years. Factors associated with good health were explored using 
weighted logistic regression models. Decomposition analysis of the CIs by “legiti-
mate” (age, sex, marital status, number of household members) and “illegitimate” 
(income, ethnicity, rural/urban, education, occupation, type of health care provision) 
factors was conducted. Results: Results indicated that there was a significant 
concentration of fair/good SRHS favoring the rich people in Chile in both years 
(Erreygers corrected CI for bounded binary variables was 0.165 [Standard Error 0.007] 
in 2000 and 0.053 [0.002] in 2009). We standardized the 2000 and 2009 CIs to assess 
horizontal inequity and decomposed them into “legitimate” factors such as age 
and sex and “illegitimate” factors, mostly socioeconomic conditions. Despite the 
fact that the CIs are not directly comparable between 2000 and 2009, our findings 
suggest that the CI might have decreased after the reform, but good SRHS continued 
Procedimiento: Los datos usados en este estudio hacen parte de la validación del 
instrumento OTAS (Observational Teamwork Assessment for Surgery) en Colombia. 
Una observadora experta en el OTAS ingresó a las salas de cirugía y registró los 
puntajes otorgados a cada subequipo (anestesiólogos, cirujanos, enfermeros e 
instrumentadores quirúrgicos) en cinco comportamientos (comunicación, coordi-
nación, cooperación, liderazgo y conciencia situacional) para las tres fases quirúr-
gicas (pre, intra y post operatorio). Se aplicó la prueba U de Mann-Whitney, se hizo 
la corrección de Bonferroni para el alfa rechazando la hipótesis nula cuando el 
alfa era igual o menor a 0,004, manteniendo así un margen de error para el estudio 
de 5%. ResultAdos: Se encontró que los puntajes obtenidos en el OTAS fueron 
diferentes en la institución privada comparada con la pública (Z= 4,77; p= 0,0000), 
al realizar comparaciones discriminadas se encontraron diferencias significativas 
en los subequipos de anestesiología (Z= 12,17; p= 0,0000), en los comportamientos 
de liderazgo (Z= 3,56; p= 0,0004) y conciencia situacional (Z= 3,20; p= 0,001) y en las 
fases pre quirúrgica (Z= 4,41; p= 0,0000) y post quirúrgica (Z= 4,20; p= 0,0000), en 
todos estos casos los puntajes fueron mayores en los equipos de la institución 
privada. ConClusiones: Teniendo en cuenta el diseño los resultados no pueden 
ser generalizados. Los hallazgos sugieren una diferencia en algunas habilidades 
no técnicas e interacción en los equipos de salud según el tipo de institución, esto 
puede estar relacionado con cumplimiento de protocolos y mayor control de calidad 
implementados en la institución privada.
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bACkgRound: The application of Health Technology Assessment (HTA) and 
Pharmacoeconomics (PE) into real health policies in selected European countries 
(Austria, Bulgaria, Croatia, Czech Republic, Germany, Hungary, Latvia, Poland, 
Romania, Serbia, Slovakia, Slovenia, UK) was analyzed based on the outputs from 
the conference “Optimalization of Methods of PE and HTA: Importance for National 
Health Policy and Cross-Border Cooperation” (Slovakia, 10/2012). objeCtives: The 
objective of the paper was to compare the systems and to find the most transpar-
ent one based on the pre-defined criteria. Methods: The primary method used 
for the analysis was structured evaluation of the outputs from the conference. 
The other relevant information resulted from the systematic review of PUBMED, 
EMBASE and CENTRAL in years 2011-2012 extended to official websites of public 
health institutions and officially published data with the objective to select all 
papers on HTA/Pharmacoeconomics related to selected European countries. We 
evaluated 9 characteristics relevant for the decision-making process: legislative 
background, implementation, binding force, institutionalization, qualified personal 
resources availability, existed methodology/guidelines, clarity of the process, patient 
involvement in the process, and respecting the deadline of 180 days for issuing a 
decision. Results: Resulting from the analysis, of selected countries, the UK was 
shown to have the most transparent system. Germany and Austria ranked second. 
Hungary and Poland ranked third, followed by Slovakia. The least transparent sys-
tem was found in Bulgaria and Romania. ConClusions: One of the criteria was 
qualified personal resources availability that immediately discriminate systems 
in smaller central and eastern European countries. This should result in develop-
ing tailored approaches rather than copying technocratic “western” systems. The 
system prepared in Romania based on multiple criteria decision analysis principle 
could be regarded as a positive example.
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objeCtivos: Si bien la utilización de Evaluación de Tecnologías (ETS) para la toma 
de decisiones es cada vez más utilizada en Argentina, es habitual la disociación 
entre el tiempo para la toma de decisiones cotidianas y el que demanda la reali-
zación de informes tradicionales. El Instituto de Efectividad Clínica y Sanitaria 
(IECS), una de las principales agencias de ETS de Latinoamérica, provee informes a 
instituciones públicas, de seguridad social y seguros privados. Se diseñó un nuevo 
tipo de documento orientado a responder una consulta puntual (motivada por 
un caso real), de respuesta en 48-72 hs, denominado Informe de Mesa de Ayuda 
(IMA). El objetivo es describir la experiencia del primer año y evaluar cuáles son las 
tecnologías más solicitadas como IMA por un grupo de decisores de Argentina y 
Uruguay. MetodologíAs: Descripción y análisis de las bases de datos de IMA reali-
zados por IECS. ResultAdos: Entre enero de 2011 y febrero de 2013 se realizaron 
110 IMA. El 78% de los pedidos correspondieron tecnologías terapéuticas (54% dis-
positivos, 26% procedimientos y 20% radioterapia), 15% a drogas y 7% a tecnologías 
diagnósticas. Esta distribución fue significativamente diferente a la observada 
en los informes de ETS donde se observa que el 52% de los pedidos correspondi-
eron a tecnologías terapéuticas, 34% a drogas y 14% a tecnologías diagnósticas. En 
cuanto a las áreas de interés el 17% de los IMA fueron relacionados con cáncer, 
el 14% con alteraciones neurológicas, el 12% con patologías traumatológicas, 11% 
gastrointestinal, 11% con trastornos urinarios, siguiendo en frecuencia motivos 
quirúrgicos, cardiovasculares, endocrinológicos, trastornos genéticos y oftalmológi-
